Mazor Robotics Ltd. (MZOR) to Release Earnings on Tuesday

Mazor Robotics Ltd. (NASDAQ:MZOR) is set to release its earnings data before the market opens on Tuesday, November 7th. Analysts expect Mazor Robotics to post earnings of ($0.22) per share for the quarter.

Mazor Robotics Ltd. (MZOR) traded up $3.00 during trading on Monday, hitting $60.23. The stock had a trading volume of 816,049 shares, compared to its average volume of 816,608.

Several research firms have recently issued reports on MZOR. Ladenburg Thalmann Financial Services set a $67.00 target price on Mazor Robotics and gave the stock a “buy” rating in a research report on Monday, October 30th. Zacks Investment Research upgraded Mazor Robotics from a “sell” rating to a “buy” rating and set a $41.00 target price for the company in a research report on Tuesday, August 15th. Barclays PLC restated a “hold” rating and set a $34.00 target price on shares of Mazor Robotics in a research report on Wednesday, October 11th. Finally, Needham & Company LLC restated a “hold” rating on shares of Mazor Robotics in a research report on Wednesday, August 30th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. Mazor Robotics presently has a consensus rating of “Hold” and an average price target of $39.83.

WARNING: “Mazor Robotics Ltd. (MZOR) to Release Earnings on Tuesday” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at

Mazor Robotics Company Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Earnings History for Mazor Robotics (NASDAQ:MZOR)

What are top analysts saying about Mazor Robotics Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mazor Robotics Ltd. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit